Verona Pharma Plc - Adr Share Price

NASDAQ: VRNA

Small Cap

$106.30

+0.03

(+0.03%)

as on September 18, 2025 at 1:29 am IST

$₹

Verona Pharma Plc - Adr Stock Performance

as on September 18, 2025 at 1:29 am IST

Day's Low
Day's High
$106.18
Day's Price Range
$106.38
$106.3
0.11%
Downside
0.08%
Upside
52 Week's Low
52 Week's High
$27.54
52-Week Price Range
$106.45
$106.3
74.09%
Downside
0.14%
Upside

Verona Pharma Plc - Adr share price movements today

Previous Close: $106.27
Open: $106.35
Volume: 2.7M
Day's Low - High: $106.18 - $106.38
52 Week Low - High: $27.54 - $106.45

Verona Pharma Plc - Adr Historical Returns

1 Month Return: + 0.95 %
3 Month Return: + 14.35 %
1 Year Return: + 264.06 %
3 Year Return: + 942.89 %
5 Year Return: 0 %

Verona Pharma Plc - Adr Stock Fundamentals & Key Indicators

Check Verona Pharma Plc - Adr market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$9.0B

EPS (TTM)

0.025

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-26.59

Industry PE ratio

-3.9281873111782475

P/B Ratio

PEG Ratio

EBITDA

-52.7M

Revenue (TTM)

221.7M

Profit Margin

-36.63%

Return On Equity TTM

0.00%

Verona Pharma Plc - Adr Stock Valuation

Track how Verona Pharma Plc - Adr P/E has moved over time to understand its valuation trends.

Verona Pharma Plc - Adr in the last 5 years

Overview
Trends

Lowest (0.00x)

September 17, 2025

Today (-26.59x)

September 17, 2025

Industry (-3.93x)

September 17, 2025

Highest (0.00x)

September 17, 2025

LowHigh

Today’s Price to Earnings Ratio: -26.59x

Verona Pharma Plc - Adr vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Verona Pharma Plc - Adr with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Verona Pharma Plc - Adr	BUY	$9.0B	NA	-26.59	-36.63%
Alnylam Pharmaceuticals, Inc.	BUY	$60.5B	252.04%	-505.15	-12.96%
Beone Medicines Ltd	NA	$39.0B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$100.3B	44.17%	27.85	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$59.6B	1.78%	14.1	31.37%

Stock Returns calculator for Verona Pharma Plc - Adr Stock including INR - Dollar returns

The Verona Pharma Plc - Adr stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Verona Pharma Plc - Adr investment value today

Current value as on today

₹3,68,764

Returns

₹2,68,764

(+268.76%)

Returns from Verona Pharma Plc - Adr Stock

₹2,64,166 (+264.17%)

Dollar Returns*

₹4,598 (+4.6%)

Analyst Recommendation on Verona Pharma Plc - Adr Stock

Based on 13 analysts

BUY

92.31%

Buy

7.69%

Hold

0.00%

Sell

Based on 13 analysts, 92.31% of analysts recommend a 'BUY' rating for Verona Pharma Plc - Adr. Average target price of $106.22

Verona Pharma Plc - Adr Share Price Target

Get share price movements and forecasts by analysts on Verona Pharma Plc - Adr.

What analysts predicted

-0.08%DOWNSIDE

Target Price

$106.22

Current Price

$106.3

Analyzed by

13 Analysts

Target

$106.22

Verona Pharma Plc - Adr target price $106.22, a slight downside of -0.08% compared to current price of $106.3. According to 13 analysts rating.

Verona Pharma Plc - Adr Stock's Interest Amongst Investors

Search interest for Verona Pharma Plc - Adr Stock has increased by 6% in the last 30 days, reflecting an upward trend in search activity.

Time period: August 19, 2025 to September 18, 2025

Change:6% versus previous 30 day period

Verona Pharma Plc - Adr Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	-	-	-	1	-	-	7	36	76	103
Gross Profit	0	0	0	0	0	0	6	34	72	98
Operating Income	-22	-9	-14	-19	-27	-68	-40	-18	-10	13
EBITDA	-15	-8	-13	-14	-23	-53	-34	-14	-6	18
Interest Expense	0	0	0	0	1	1	9	10	10	6
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-16	-8	-14	-15	-25	-70	-42	-25	-16	11
Income Tax Expense	0	0	0	-1	0	0	0	8	0	0
Net Income	-20	-11	-18	-18	-32	-90	-56	-33	-16	11
Net Profit Margin	0.00%	0.00%	0.00%	-1516.39%	0.00%	0.00%	-763.90%	-92.28%	-21.40%	11.56%

Verona Pharma Plc - Adr Annual Profit & Loss

All numbers in Millions USD

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	-	2	0	0	0	53	0	0	42
Gross Profit	-	-	2	0	0	0	53	0	0	39
Operating Income	-13	-8	-40	-32	-53	-74	-73	-66	-67	-154
EBITDA	-8	-6	-29	-25	-32	-47	-42	-67	-52	-142
Interest Expense	-	0	0	0	0	0	0	0	2	23
Depreciation	-	-	0	0	0	0	0	0	0	1
Income Before Tax	-13	-7	-34	-30	-51	-65	-55	-68	-55	-163
Income Tax Expense	-2	-1	-6	-5	-9	0	0	0	0	6
Net Income	-16	-7	-37	-31	-54	-87	-73	-83	-68	-173
Net Profit Margin	0.00%	0.00%	-1504.60%	-907384.56%	-1781367.49%	-2770991.07%	-138.92%	-15000.22%	-11870.96%	-410.18%

Verona Pharma Plc - Adr Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-8	-14	-14	-25	-70	-42	-33	-16	11
Operating Cash Flow	-21	-12	-10	-13	-16	-62	-28	-11	30
Investing Cash Flow	-	-	0	0	0	0	0	0	-
Financing Cash Flow	0	0	24	-2	166	-7	94	13	4
Change in Cash	-20	-13	14	-16	149	-68	63	1	36

Verona Pharma Plc - Adr Annual Cash Flow

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-7	-34	-30	-51	-65	-55	-68	-54	-173
Operating Cash Flow	-6	-27	-22	-44	-45	-33	-59	-50	-122
Investing Cash Flow	0	-66	6	49	9	0	0	-	0
Financing Cash Flow	50	85	0	0	192	-6	140	92	250
Change in Cash	44	-11	-14	4	157	-39	79	43	127

Global Institutional Holdings in Verona Pharma Plc - Adr

Funds	Holdings
Perceptive Advisors LLC	7.61%
HHG PLC	6.4%
Darwin Global Management, Ltd.	4.55%
Eventide Asset Management, LLC	3.36%
RTW INVESTMENTS, LLC	3.31%

See all

Insights on Verona Pharma Plc - Adr

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Best in 3 Years
In the last 3 years, VRNA has outperformed top 5 stocks with highest market-cap in its industry
POSITIVE IMPACT
Best in 1 Year
In the last 1 year, VRNA has outperformed top 5 stocks with highest market-cap in its industry
POSITIVE IMPACT
Price Rise
In the last 3 years, VRNA stock has moved up by 942.9%

About Verona Pharma Plc - Adr

verona pharma is a clinical stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of respiratory diseases with significant unmet medical needs. we are currently focused on developing our novel lead therapeutic candidate in the treatment of chronic obstructive pulmonary fibrosis (copd) and cystic fibrosis (cf), and may expand our pipeline to help address the gaps in treatment of other respiratory diseases. we are led by a team with deep industry experience, including extensive backgrounds in the discovery, development and commercialization of respiratory therapies. in addition, we have established relationships with leading research institutions and advocacy organizations in the respiratory space and have received awards in support of our continued work and innovation. verona pharma is listed on the nasdaq global market in the united states under the ticker symbol vrna and on the london stock exchange in the united kin

Organisation	Verona Pharma Plc - Adr
Headquarters	3 More London Riverside, London, United Kingdom, SE1 2RE
Industry	Health Technology
CEO	Dr. David Scott Zaccardelli Pharm.D.
E-voting on shares	Click here to vote

Key Management of Verona Pharma Plc - Adr

Name	Title
Mr. Matthew Casbon	VP of Sales, Marketing & Training
Dr. Tara Rheault M.P.H., Ph.D.	Chief Development Officer
Ms. Caroline Diaz	Chief Regulatory Officer
Dr. David Scott Zaccardelli Pharm.D.	President, CEO & Executive Director
Mr. Mark W. Hahn CPA	Chief Financial Officer
Mr. Andrew Fisher	General Counsel
Mr. Christopher Martin	Chief Commercial Officer
Dr. Kathleen A. Rickard M.D.	Chief Medical Officer
Ms. Victoria Stewart	Senior Director of Investor Relations & Communications
Ms. Ostra Jewell	Senior Vice President of Human Resources

FAQs

What is Verona Pharma Plc - Adr share price today?

Verona Pharma Plc - Adr share price today is $106.3 as on September 18, 2025 at 1:29 am IST at the close of the market. Verona Pharma Plc - Adr share today touched a day high of $106.38 and a low of $106.18.

What is the 52 week high and 52 week low for Verona Pharma Plc - Adr share?

Verona Pharma Plc - Adr share touched a 52 week high of $106.45 on September 15, 2025 and a 52 week low of $27.54 on September 27, 2024. Verona Pharma Plc - Adr stock price today i.e. September 18, 2025 at 1:29 am IST is closed at $106.3,which is 0.14% down from its 52 week high and 285.98% up from its 52 week low.

What is Verona Pharma Plc - Adr's market capitalisation today?

Verona Pharma Plc - Adr market capitalisation is $0.01T as on September 18, 2025 at 1:29 am IST.

How to invest in Verona Pharma Plc - Adr Stock (VRNA) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Verona Pharma Plc - Adr on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Verona Pharma Plc - Adr Shares that will get you 0.0141 shares as per Verona Pharma Plc - Adr share price of $106.3 per share as on September 18, 2025 at 1:29 am IST.

What is the minimum amount required to buy Verona Pharma Plc - Adr Stock (VRNA) from India?

Indian investors can start investing in Verona Pharma Plc - Adr (VRNA) shares with as little as ₹87.816 or $1 (as of September 18, 2025 at 2:42 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹878.16 in Verona Pharma Plc - Adr stock (as per the Rupee-Dollar exchange rate as on September 18, 2025 at 2:42 am IST). Based on Verona Pharma Plc - Adr share’s latest price of $106.3 as on September 18, 2025 at 1:29 am IST, you will get 0.0941 shares of Verona Pharma Plc - Adr. Learn more about fractional shares .